The new FDA release is guidance. For trials still
Post# of 148179
Quote:
The choice, time frame, and interpretation of endpoints may differ depending on the population evaluated in the trial.
In a trial in severe and/or critically ill patients, examples of appropriate endpoints could be
https://www.fda.gov/media/137926/download